CD8A and neoplasm: (73) demonstrated that oncolytic AdV expressing human IL-2 achieved the local release of IL-2 in hamster pancreatic cancer, improved the efficacy of adoptive cell therapy, and significantly enhanced the infiltration of CD8+ T cells into the tumor microenvironment, while avoiding systemic toxicity caused by a intravenous delivery of IL-2.